Postdoctoral and Predoctoral Fellowship NCI T32 Training Program in Translational Genomics and Precision Medicine in Cancer
Job posting number: #7055283
Posted: January 15, 2019
Application Deadline: March 1, 2019
Job DescriptionELIGIBILITY REQUIREMENTS: Postdoctoral fellows must be U.S. citizens or have permanent residence. The current Predoctoral fellows positions associated with the T32 have no U.S. citizenship required.
The NCI T32 in Translational Genomics and Precision Medicine in Cancer (TGP) training program invites applicants for its inaugural postdoctoral and predoctoral training program at the University of Texas MD Anderson Cancer Center. The T32 program was developed in response to a new revolution of Big Data and the need for scientists to be trained in the discovery, integration and interpretation of translational genomics for precision medicine. The training plan allows qualified predoctoral or postdoctoral candidates to be educated and trained in-depth and breadth in state-of-the-art areas of translational genomics and precision medicine related to cancer. The goal is to educate and train the next generation of scientists to understand broadly their role in driving precision medicine through discovery science and development of novel genomic analytical tools necessary to power this application in the clinical setting. In addition to a mentored research experience by one of our outstanding training faculty, both PhD candidates and postdoctoral fellows are expected to gain interdisciplinary training in core competency areas critical to the future of translational genomic science.
Core Competencies for the program include a depth and breadth of knowledge in 5 areas: 1) translational cancer research, to gain exposure to mechanistic studies in translational research and their importance to the human organism; 2) precision medicine to gain experience in state-of-the-art ways to diagnose and target treatment of cancer patients based on genomic or immunogenetic profiles; 3) translational genetics and genomics, to gain competency in translational genomics needed for future understanding and implementation of cancer precision medicine; 4) bioinformatics, to learn how to read and interpret large omics datasets; and, 5) exposure to relevant tumor boards (monthly) and to industrial collaborations with academic faculty mentors on large scale genomic applications in cancer precision medicine.
T32 Departments & Faculty Mentors:
• Krishna Bhat, PhD
• Peng Huang, MD, PhD
• Ann Killary, PhD
• Larry Kwong PhD
• Sue-Hwa Lin, PhD
• Sendurai Mani, PhD
• Subrata Sen, PhD
• Rama Soundararajan, PhD
• Ignacio Wistuba, MD
Clinical Cancer Prevention
• Florencia McAllister, MD
• Eduardo Vilar-Sanchez, MD
• Paul Scheet, PhD
• XiFeng Wu, PhD
• Nick Navin, PhD
• Ralf Krahe, PhD
Melanoma Medical Oncology
• Chantale Bernatchez, PhD
Hematopathology and Pathology
• Timothy McDonnell, MD, PhD
• Anirban Maitra, MD, MBBS
Encouraging Diversity. The training program is committed to ensuring diversity in selecting outstanding fellows for the program. Minority, disadvantaged or disabled applicants are encouraged to apply.
For more information please contact the T32 Leadership Team:
Dr. Ann Killary, Ph.D., Professor, Translational Molecular Pathology, firstname.lastname@example.org
Dr. Ignacio Wistuba, M.D., Chair, Translational Molecular Pathology, email@example.com
Jeannette McGee, Education Program Coordinator, Translational Molecular Pathology, JMcGee@mdanderson.org
M. D. Anderson Cancer Center is an equal opportunity employer and does not discriminate on basis of race, color, national origin, gender, sexual orientation, age, religion, disability or veteran status except where such distinction is required by law. All positions at The University of Texas M. D. Anderson Cancer Center are security sensitive and subject to examination of criminal history record information. Smoke-free and drug-free environment.